Detalhe da pesquisa
1.
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.
Biol Blood Marrow Transplant
; 26(8): e177-e182, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438042
2.
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing.
Blood
; 118(17): 4732-9, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21868572
3.
Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.
Biol Blood Marrow Transplant
; 15(12): 1609-19, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19744572
4.
Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].
Transplant Cell Ther
; 28(10): 715-716, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202526
5.
Cytoprotection in acute myelogenous leukemia (AML) therapy.
Semin Oncol
; 31(6 Suppl 18): 67-73, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15726527
6.
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
Biol Blood Marrow Transplant
; 13(1): 74-81, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17222755